Tilsotolimod Uses, Dosage, Side Effects and more
Tilsotolimod is under investigation in clinical trial NCT03865082 (Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)).
| Trade Name | Tilsotolimod |
| Generic | Tilsotolimod |
| Tilsotolimod Other Names | Tilsotolimod |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
